ALEMBIC Quarterly Results
| Consolidated | Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹74 Cr | ₹56 Cr | ₹50 Cr | ₹60 Cr | ₹58 Cr | ₹53 Cr | ₹51 Cr | ₹49 Cr |
| Expenses | ₹47 Cr | ₹33 Cr | ₹30 Cr | ₹33 Cr | ₹32 Cr | ₹33 Cr | ₹30 Cr | ₹25 Cr |
| Operating Income | ₹27 Cr | ₹23 Cr | ₹20 Cr | ₹27 Cr | ₹26 Cr | ₹20 Cr | ₹20 Cr | ₹24 Cr |
| Other Income | ₹2 Cr | ₹65 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹66 Cr | ₹2 Cr | ₹2 Cr |
| Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹1 Cr |
| Profit Before Tax | ₹26 Cr | ₹85 Cr | ₹20 Cr | ₹27 Cr | ₹27 Cr | ₹82 Cr | ₹19 Cr | ₹24 Cr |
| Profit After Tax | ₹22 Cr | ₹76 Cr | ₹18 Cr | ₹24 Cr | ₹26 Cr | ₹77 Cr | ₹17 Cr | ₹21 Cr |
| EPS | ₹2.34 | ₹5.00 | ₹2.40 | ₹2.67 | ₹2.55 | ₹4.71 | ₹2.17 | ₹2.81 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ALEMBIC | -3.2% | -1.5% | -9.4% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.3% | 9% | 8.6% |
| DIVIS LABORATORIES | 1.9% | 5.9% | 12.6% |
| CIPLA | 1.6% | 1.8% | -7.9% |
| TORRENT PHARMACEUTICALS | 0.6% | 9.5% | 45% |
| DR REDDYS LABORATORIES | -1.5% | 5.7% | 14.5% |
| MANKIND PHARMA | 9.9% | 5.8% | -2% |
| ZYDUS LIFESCIENCES | 1.6% | 4.2% | 6% |
| LUPIN | 2.5% | 7% | 21.9% |
ALEMBIC Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 33.08 % |
| Y-o-Y | 28.35 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Dec2025 | ₹74 Cr | 33.08 | |
| Sep2025 | ₹56 Cr | 12.28 | |
| Jun2025 | ₹50 Cr | -17.45 | |
| Mar2025 | ₹60 Cr | 4.06 | |
| Dec2024 | ₹58 Cr | 9.47 | |
| Sep2024 | ₹53 Cr | 4.19 | |
| Jun2024 | ₹51 Cr | 3.55 | |
| Mar2024 | ₹49 Cr | - | |
ALEMBIC Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 18.07 % |
| Y-o-Y | 3.94 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Dec2025 | ₹27 Cr | 18.07 | |
| Sep2025 | ₹23 Cr | 18.75 | |
| Jun2025 | ₹20 Cr | -28.37 | |
| Mar2025 | ₹27 Cr | 3.48 | |
| Dec2024 | ₹26 Cr | 34.90 | |
| Sep2024 | ₹20 Cr | -4.07 | |
| Jun2024 | ₹20 Cr | -15.53 | |
| Mar2024 | ₹24 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -11.27 % |
| Y-o-Y | -19.02 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Dec2025 | 36.91% | -11.27 | |
| Sep2025 | 41.6% | 5.74 | |
| Jun2025 | 39.34% | -13.21 | |
| Mar2025 | 45.33% | -0.55 | |
| Dec2024 | 45.58% | 23.22 | |
| Sep2024 | 36.99% | -7.92 | |
| Jun2024 | 40.17% | -18.44 | |
| Mar2024 | 49.25% | - | |
ALEMBIC Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -70.46 % |
| Y-o-Y | -13.88 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Dec2025 | ₹22 Cr | -70.46 | |
| Sep2025 | ₹76 Cr | 327.30 | |
| Jun2025 | ₹18 Cr | -25.05 | |
| Mar2025 | ₹24 Cr | -8.97 | |
| Dec2024 | ₹26 Cr | -66.25 | |
| Sep2024 | ₹77 Cr | 343.80 | |
| Jun2024 | ₹17 Cr | -18.18 | |
| Mar2024 | ₹21 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -77.80 % |
| Y-o-Y | -32.88 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Dec2025 | 30.23 % | -77.80 | |
| Sep2025 | 136.16 % | 280.55 | |
| Jun2025 | 35.78 % | -9.21 | |
| Mar2025 | 39.41 % | -12.50 | |
| Dec2024 | 45.04 % | -69.18 | |
| Sep2024 | 146.12 % | 326.01 | |
| Jun2024 | 34.3 % | -20.99 | |
| Mar2024 | 43.41 % | - | |
ALEMBIC Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -53.20 % |
| Y-o-Y | -8.24 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Dec2025 | ₹2.34 | -53.20 | |
| Sep2025 | ₹5 | 108.33 | |
| Jun2025 | ₹2.4 | -10.11 | |
| Mar2025 | ₹2.67 | 4.71 | |
| Dec2024 | ₹2.55 | -45.86 | |
| Sep2024 | ₹4.71 | 117.05 | |
| Jun2024 | ₹2.17 | -22.78 | |
| Mar2024 | ₹2.81 | - | |
You may also like the below Video Courses